Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16271750 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
Condition: Cervical Cancer
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride

Indicates status has not been verified in more than two years